Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2023) 93 OC6 | DOI: 10.1530/endoabs.93.OC6

1‘C.I.Parhon’ National Institute of Endocrinology, Clinical Endocrinology I, Bucharest, Romania; 2‘Carol Davila’ University of Medicine and Pharmacy; ‘C.I. Parhon’ Institute of Endocrinology, Bucharest, Romania; 3‘C.I.Parhon’ National Institute of Endocrinology, Romania; 4‘Carol Davila’ University of Medicine and Pharmacy, ‘C.I. Parhon’ Institute of Endocrinology, Bucharest, Romania.


Background: Adrenal incidentalomas (AI) with mild autonomous cortisol secretion (MACS) are associated with increased morbidity and mortality and constitute a common clinical scenario.

Objective: We assessed the outcome of cardiovascular risk factors associated with MACS after adrenalectomy versus conservative management.

Methods: Retrospective study performed on a cohort of patients evaluated in our clinic between 2018 and 2022 with an AI and an impaired response to 1 mg dexamethasone suppression test (DST), after exclusion of overt hormone excess, mixed hormonal secretion, malignancy and glucocorticoid medication.

Results: Of the 481 patients with AI evaluated, 14.55% had MACS, but only 10.81% were included in the study, with a median follow up of 21 months (9–77.25). 48.08% (n=25, aged 58.4±9.42 years, 96% women) underwent surgery and the other 51.92% (n=27, aged 59.52±8.05 years, 77.8% women) were managed conservatively. The mean tumor diameter was significantly higher in the surgery group (36.44±12.88 mm vs 23.79±11.3 mm), while bilateral masses were more prevalent in those conservatively treated (51.9% vs 36%). Surgery was performed in cases with higher cortisol values after 1 mg DST (3.54 μg/dl, 2.66–6.23, P=0.003) and lower ACTH levels (4.71 pg/ml, 2.51–7.06, P<0.001). Surgery was moderately correlated with an improvement in arterial hypertension (r=0.351, P=0.014), 45.45% of the operated patients requiring less or no hypotensive drugs compared to 11.53% non-operated patients (P=0.008). The latter showed a slightly better control of glucidic metabolism (P=0.077) and lower triglyceride levels at the last visit (P=0.026).

Conclusion: When assessing adrenalectomy as a treatment option for patients with AI and MACS, we need an individualized approach, considering our heterogeneous results and the low-to-moderate-quality evidence available in the literature comparing surgery with the best management of associated comorbid conditions in these patients.

Volume 93

ESE Young Endocrinologists and Scientists (EYES) 2023

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.